Coherus BioSciences Inc (NASDAQ:CHRS)

11.90
Delayed Data
As of Apr 20
 -0.15 / -1.24%
Today’s Change
8.05
Today|||52-Week Range
24.70
+35.23%
Year-to-Date
No recent news for Coherus BioSciences Inc.

Today’s Trading

Previous close12.05
Today’s open11.95
Day’s range11.65 - 12.25
Volume341,027
Average volume (3 months)716,517
Market cap$712.7M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-47.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.18%
P/E ratioNM
Price/Sales300.50
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.03+0.29%
NTLAIntellia Therapeutic...-0.23-1.05%
MYOVMyovant Sciences Ltd+0.37+1.78%
ADAPAdaptimmune Therapeu...+0.33+2.73%
Data as of 4:01pm ET, 04/20/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$1.6M
Annual profit (last year)-$238.2M
Net profit margin-15,306.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts